Osteopontin is a prognostic biomarker in non-small cell lung cancer

Osteopontin is a prognostic biomarker in non-small cell lung cancer

Abstract Background In a previously published report we characterized the expression of the metastasis-associated proteins S100A4, osteopontin (OPN) and ephrin-A1 in a prospectively collected panel of non-small cell lung cancer (NSCLC) tumors. The aim of the present follow-up study was to investigat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ane Kongsgaard, Kjetil Boye, Miriam Øijordsbakken, Marius Lund-Iversen, Ann Rita Halvorsen, Steinar K Solberg, Gisle Berge, Åslaug Helland, Odd Terje Brustugun, Gunhild M Mælandsmo
Format: Article
Language:English
Published: BMC 2013-11-01
Series:BMC Cancer
Subjects:
NSCLC
Prognosis
Biomarker
Osteopontin
S100A4
Online Access:https://doi.org/10.1186/1471-2407-13-540
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/1471-2407-13-540

Similar Items